Currently used medicines for Alzheimer's disease are not very effective

被引:0
|
作者
Brenner, Steven [1 ]
机构
[1] St Louis VA Med Ctr, Dept Neurol, St Louis, MO 63125 USA
[2] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA
来源
AMERICAN JOURNAL OF MEDICINE | 2007年 / 120卷 / 12期
关键词
D O I
10.1016/j.amjmed.2007.05.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E25 / E25
页数:1
相关论文
共 50 条
  • [41] Is an effective immune intervention for Alzheimer's disease in prospect?
    Esiri, MM
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (01) : 2 - 3
  • [42] Apathy in Alzheimer's Disease: Any Effective Treatment?
    Rea, Raffaele
    Carotenuto, Anna
    Fasanaro, Angiola M.
    Traini, Enea
    Amenta, Francesco
    [J]. SCIENTIFIC WORLD JOURNAL, 2014,
  • [44] The development of effective biomarkers for Alzheimer's disease: a review
    Henry, Mark S.
    Passmore, Anthony P.
    Todd, Stephen
    McGuinness, Bernadette
    Craig, David
    Johnston, Janet A.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 28 (04) : 331 - 340
  • [45] Effective caregiving approaches for patients with Alzheimer's disease
    Burgener, SC
    Bakas, T
    Murray, C
    Dunahee, J
    Tossey, S
    [J]. GERIATRIC NURSING, 1998, 19 (03) : 121 - 126
  • [46] Magnesium may be an effective therapy for Alzheimer's disease
    Lei, Dao-Yun
    Sun, Jie
    [J]. WORLD JOURNAL OF PSYCHIATRY, 2022, 12 (09): : 1261 - 1263
  • [47] Risperidone is effective in patients with psychosis of Alzheimer's disease
    Brodaty, H
    De Deyn, P
    Katz, I
    Lyons, B
    Greenspan, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S205 - S206
  • [48] The need for thorough phase II studies in medicines development for Alzheimer’s disease
    Julian A. Gray
    David Fleet
    Bengt Winblad
    [J]. Alzheimer's Research & Therapy, 7
  • [49] Huperzine A: is it an effective disease-modifying drug for Alzheimer's disease?
    Qian, Zhong Ming
    Ke, Ya
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [50] The need for thorough phase II studies in medicines development for Alzheimer's disease
    Gray, Julian A.
    Fleet, David
    Winblad, Bengt
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2015, 7